UNIGE document Scientific Article - Case report
previous document  unige:19639  next document
add to browser collection
Title

Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure

Authors
Announ, Nadia
Palmer, Gaby
Published in Joint, Bone, Spine. 2009, vol. 76, no. 4, p. 424-426
Abstract We describe the case of a 71-year-old man with recurrent pseudogout attacks affecting multiple joints. He had end-stage renal failure that contra-indicated the use of non-steroidal anti-inflammatory drugs and was resistant to therapy with glucocorticoids. Based on the recent findings that interleukin (IL)-1beta is involved in crystal-induced inflammation, the patient received anakinra, a specific IL-1 inhibitor, in order to treat an acute attack of pseudogout. In addition, anakinra was administered as preventive therapy 3days per week after each hemodialysis session. Under this treatment, he did not present any severe episode of arthritis after a follow-up of 8 months. This observation suggests that anakinra is efficacious and safe for the prevention of crystal-induced arthritis in patients with severe renal failure.
Keywords AgedAnti-Inflammatory Agents, Non-Steroidal/*contraindicationsAntirheumatic Agents/*therapeutic useChondrocalcinosis/complications/*drug therapy/*prevention & controlHumansInterleukin 1 Receptor Antagonist Protein/*therapeutic useInterleukin-1/antagonists & inhibitorsKidney Failure, Chronic/*complicationsMaleTreatment Outcome
Identifiers
PMID: 19289295
Full text
Structures
Research group Mécanisme de l'inflammation articulaire (44)
Citation
(ISO format)
ANNOUN, Nadia et al. Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure. In: Joint, Bone, Spine, 2009, vol. 76, n° 4, p. 424-426. https://archive-ouverte.unige.ch/unige:19639

113 hits

0 download

Update

Deposited on : 2012-04-23

Export document
Format :
Citation style :